Fig. 12From: Analysis of the role of thrombomodulin in all-trans retinoic acid treatment of coagulation disorders in cancer patientsVariations in the cellular level of TM and the plasma concentration of sTM within three days of RA treatment. Daily doses of RA are taken at t = 0 h, t = 24 h, and t = 48 h. (a) \( 45\frac{mg}{m^2} \) and (b) 110 \( \frac{mg}{m^2} \). Solid lines are the mean simulated values. Shaded regions show the 99% confidence interval of the mean resultsBack to article page